Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you are on Mounjaro and thinking about trying for a baby, the clinical guidance is clear: tirzepatide is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. The decision is not about whether Mounjaro has been proved harmful — it is about the fact that safety during pregnancy has not been established, and no prescriber can responsibly leave that question open. Stopping in advance, under medical supervision, is the recommended step. These medicines are prescription-only, and any plan to stop, pause or switch treatment must be led by your prescriber or GP.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The honest answer is that we don't have human pregnancy safety data for tirzepatide. That absence of evidence is itself the reason for caution. Reproductive toxicology studies in animals found adverse outcomes at doses that produce exposures higher than those used clinically, but the relevance to humans cannot be dismissed when the stakes are this high. The Mounjaro Summary of Product Characteristics, available on the Electronic Medicines Compendium, specifies that the medicine must not be used during pregnancy.
The NHS reinforces this position across its guidance on weight-management injections. A precautionary approach is entirely standard when a medicine's safety in early fetal development cannot be confirmed. Your growing baby's organ systems are forming in the first trimester before many people even know they are pregnant, which is exactly why the guidance asks you to plan ahead rather than stop only once a positive test appears.
There is also a practical consideration worth naming: Mounjaro slows gastric emptying and reduces appetite significantly. The nutritional demands of early pregnancy (adequate folate, calories, protein) sit in tension with those effects. That is not a theoretical concern. It is a reason clinicians want a clear gap between stopping treatment and conception.
One thing our prescribers hear regularly is this: weight loss itself can restore ovulation in women with conditions such as polycystic ovary syndrome, where fertility had previously been unpredictable. That means getting pregnant on tirzepatide is not simply an abstract risk, it is something that can happen to people who assumed it wouldn't. Effective contraception while you are on treatment is not optional.
There is an additional layer for anyone using the oral contraceptive pill. Because tirzepatide slows the movement of food and medicine through the gut, pill absorption may be reduced, particularly in the early weeks of treatment and after each dose increase. NHS England's guidance on weight-management injections advises adding a non-oral method (condoms, for example) for the first four weeks of treatment and for four weeks after each dose step up. Long-acting options such as an intrauterine device or implant are unaffected by this concern.
If you are thinking about whether you can get pregnant on Mounjaro, the position is nuanced. The medicine is not a contraceptive, and improved metabolic health alongside weight loss may actually increase fertility for some women. You can read more about whether Mounjaro can stop you from getting pregnant, including what the current evidence does and does not tell us about the medicine's effect on fertility.
Stopping abruptly without a plan is not the right approach. The correct route is a conversation with your prescriber or GP before you stop, so you can discuss the wash-out period, any nutritional preparations (folic acid supplementation, for instance), and what support is available for maintaining your health without the medicine.
The MHRA advises that effective contraception should be used during treatment and for a defined period after the final dose, your prescriber will give you a specific timeframe based on current guidance and your circumstances. You can read more about the MHRA's reporting system if you experience anything unexpected during any transition period.
At nume, every repeat order goes through a fresh clinical review by a GPhC-registered prescriber, a real clinician reads your notes, not a system running automated checks. If your circumstances change, including plans to conceive, that review is the moment to say so. You can also contact our team directly if you need to speak to someone before your next order. Our clinical approach is described more fully on the clinical team page.
There is no single right answer to how long you should wait between stopping Mounjaro and trying to conceive, that depends on the dose you were on, how long you were taking it, and your wider health picture. What is clear is that planning ahead gives you the best chance of a healthy outcome, both for your weight management journey and for a future pregnancy.
If you are not yet on treatment and are considering how Mounjaro works as part of a longer health plan that includes starting a family, it is worth raising that timeline at the outset. A prescriber who knows your full picture can help you structure your treatment sensibly, for example, aiming to reach and consolidate a healthier weight before transitioning off. You can explore weight-loss treatments available through nume, and if you have questions about being pregnant on Mounjaro, that guide covers the topic in more detail. There are also real accounts from women who have become pregnant while taking Mounjaro, which offer useful context alongside the clinical guidance.
If you are ready to have that clinical conversation, a free consultation is the place to start. Your consultation is reviewed the same day by one of our prescribers. If treatment is clinically appropriate, your medication arrives in plain, unbranded packaging via DPD, you will get a tracking link so you know exactly when to expect it. That is the same careful process that applies whether you are starting treatment, pausing it, or planning around a future pregnancy.
Start your free consultation and speak to a prescriber about your plans.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.